JP2020517299A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020517299A5 JP2020517299A5 JP2020507491A JP2020507491A JP2020517299A5 JP 2020517299 A5 JP2020517299 A5 JP 2020517299A5 JP 2020507491 A JP2020507491 A JP 2020507491A JP 2020507491 A JP2020507491 A JP 2020507491A JP 2020517299 A5 JP2020517299 A5 JP 2020517299A5
- Authority
- JP
- Japan
- Prior art keywords
- dna
- donor
- sequence
- repair template
- double
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108020004414 DNA Proteins 0.000 claims 20
- 238000000034 method Methods 0.000 claims 17
- 230000033616 DNA repair Effects 0.000 claims 9
- 210000003527 eukaryotic cell Anatomy 0.000 claims 8
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 7
- 238000010362 genome editing Methods 0.000 claims 6
- 230000004048 modification Effects 0.000 claims 6
- 238000012986 modification Methods 0.000 claims 6
- 239000002773 nucleotide Substances 0.000 claims 5
- 125000003729 nucleotide group Chemical group 0.000 claims 5
- 238000010356 CRISPR-Cas9 genome editing Methods 0.000 claims 3
- 230000005782 double-strand break Effects 0.000 claims 3
- 108091033409 CRISPR Proteins 0.000 claims 2
- 108020005004 Guide RNA Proteins 0.000 claims 2
- 108091028113 Trans-activating crRNA Proteins 0.000 claims 2
- 108010017070 Zinc Finger Nucleases Proteins 0.000 claims 2
- 230000001105 regulatory effect Effects 0.000 claims 2
- 108020005065 3' Flanking Region Proteins 0.000 claims 1
- 108020005029 5' Flanking Region Proteins 0.000 claims 1
- 238000010354 CRISPR gene editing Methods 0.000 claims 1
- 101710163270 Nuclease Proteins 0.000 claims 1
- 230000003321 amplification Effects 0.000 claims 1
- 239000012636 effector Substances 0.000 claims 1
- 239000012634 fragment Substances 0.000 claims 1
- 230000002068 genetic effect Effects 0.000 claims 1
- 210000004602 germ cell Anatomy 0.000 claims 1
- 238000003199 nucleic acid amplification method Methods 0.000 claims 1
- 238000005096 rolling process Methods 0.000 claims 1
- 230000002103 transcriptional effect Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15/491,125 US11834670B2 (en) | 2017-04-19 | 2017-04-19 | Site-specific DNA modification using a donor DNA repair template having tandem repeat sequences |
| US15/491,125 | 2017-04-19 | ||
| PCT/US2018/028366 WO2018195313A1 (en) | 2017-04-19 | 2018-04-19 | Site-specific dna modification using a donor dna repair template having tandem repeat sequences |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020517299A JP2020517299A (ja) | 2020-06-18 |
| JP2020517299A5 true JP2020517299A5 (OSRAM) | 2021-05-27 |
| JP7292258B2 JP7292258B2 (ja) | 2023-06-16 |
Family
ID=62196680
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020507491A Active JP7292258B2 (ja) | 2017-04-19 | 2018-04-19 | 縦列反復配列を有するドナーｄｎａ修復鋳型を使用する部位特異的なｄｎａ改変 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US11834670B2 (OSRAM) |
| EP (1) | EP3612630B1 (OSRAM) |
| JP (1) | JP7292258B2 (OSRAM) |
| CN (1) | CN110709514B (OSRAM) |
| CA (1) | CA3062154A1 (OSRAM) |
| WO (1) | WO2018195313A1 (OSRAM) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20180250424A1 (en) | 2014-10-10 | 2018-09-06 | Editas Medicine, Inc. | Compositions and methods for promoting homology directed repair |
| EP3215617B1 (en) | 2014-11-07 | 2024-05-08 | Editas Medicine, Inc. | Systems for improving crispr/cas-mediated genome-editing |
| WO2017053879A1 (en) | 2015-09-24 | 2017-03-30 | Editas Medicine, Inc. | Use of exonucleases to improve crispr/cas-mediated genome editing |
| WO2017165826A1 (en) | 2016-03-25 | 2017-09-28 | Editas Medicine, Inc. | Genome editing systems comprising repair-modulating enzyme molecules and methods of their use |
| US11236313B2 (en) | 2016-04-13 | 2022-02-01 | Editas Medicine, Inc. | Cas9 fusion molecules, gene editing systems, and methods of use thereof |
| WO2019014564A1 (en) | 2017-07-14 | 2019-01-17 | Editas Medicine, Inc. | SYSTEMS AND METHODS OF TARGETED INTEGRATION AND GENOME EDITING AND DETECTION THEREOF WITH INTEGRATED PRIMING SITES |
| US10350307B2 (en) * | 2017-09-18 | 2019-07-16 | General Electric Company | In vivo RNA or protein expression using double-stranded concatemeric DNA including phosphorothioated nucleotides |
| WO2019099982A1 (en) * | 2017-11-17 | 2019-05-23 | The Johns Hopkins University | Compositions and methods for efficient genome editing |
| CN112654710A (zh) | 2018-05-16 | 2021-04-13 | 辛瑟高公司 | 用于指导rna设计和使用的方法和系统 |
| CN114072498A (zh) * | 2019-07-23 | 2022-02-18 | 先锋国际良种公司 | Crispr-cas9基因组编辑的供体设计策略 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5648245A (en) * | 1995-05-09 | 1997-07-15 | Carnegie Institution Of Washington | Method for constructing an oligonucleotide concatamer library by rolling circle replication |
| EP3176263A1 (en) * | 2007-08-10 | 2017-06-07 | Toto Ltd. | Method of producing recombinant mammalian cells |
| US8921072B2 (en) | 2008-09-02 | 2014-12-30 | General Electric Compnay | Methods to generate DNA mini-circles |
| WO2011033375A2 (en) * | 2009-09-18 | 2011-03-24 | Selexis S.A. | Products and methods for enhanced transgene expression and processing |
| US9273324B2 (en) * | 2010-12-05 | 2016-03-01 | Andrew S. Belmont | Recombinant gene expression |
| EP2718446A2 (en) | 2011-06-07 | 2014-04-16 | Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) | Improved recombination efficiency by inhibition of nhej dna repair |
| RS59199B1 (sr) * | 2012-05-25 | 2019-10-31 | Univ California | Metode i jedinjenja za rnk-upravljanu ciljanu dnk modifikaciju i za rnk- upravljanu modulaciju transkripta |
| KR102479178B1 (ko) | 2012-12-06 | 2022-12-19 | 시그마-알드리치 컴퍼니., 엘엘씨 | Crispr-기초된 유전체 변형과 조절 |
| JP2016505256A (ja) | 2012-12-12 | 2016-02-25 | ザ・ブロード・インスティテュート・インコーポレイテッ | 配列操作のためのＣＲＩＳＰＲ−Ｃａｓ成分系、方法および組成物 |
| US8697359B1 (en) | 2012-12-12 | 2014-04-15 | The Broad Institute, Inc. | CRISPR-Cas systems and methods for altering expression of gene products |
| US9328382B2 (en) * | 2013-03-15 | 2016-05-03 | Complete Genomics, Inc. | Multiple tagging of individual long DNA fragments |
| US20150067922A1 (en) | 2013-05-30 | 2015-03-05 | The Penn State Research Foundation | Gene targeting and genetic modification of plants via rna-guided genome editing |
| AU2015299850B2 (en) | 2014-08-06 | 2020-08-13 | Institute For Basic Science | Genome editing using Campylobacter jejuni CRISPR/CAS system-derived RGEN |
| US20180250424A1 (en) | 2014-10-10 | 2018-09-06 | Editas Medicine, Inc. | Compositions and methods for promoting homology directed repair |
| EP3215617B1 (en) | 2014-11-07 | 2024-05-08 | Editas Medicine, Inc. | Systems for improving crispr/cas-mediated genome-editing |
| US20180094243A1 (en) * | 2015-04-03 | 2018-04-05 | Dana-Farber Cancer Institute, Inc. | Composition and methods of genome editing of b-cells |
-
2017
- 2017-04-19 US US15/491,125 patent/US11834670B2/en active Active
-
2018
- 2018-04-19 CA CA3062154A patent/CA3062154A1/en active Pending
- 2018-04-19 JP JP2020507491A patent/JP7292258B2/ja active Active
- 2018-04-19 EP EP18725682.1A patent/EP3612630B1/en active Active
- 2018-04-19 WO PCT/US2018/028366 patent/WO2018195313A1/en not_active Ceased
- 2018-04-19 CN CN201880025960.XA patent/CN110709514B/zh active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020517299A5 (OSRAM) | ||
| AU2021212165B2 (en) | Genomewide unbiased identification of dsbs evaluated by sequencing (guide-seq) | |
| Bharathkumar et al. | CRISPR/Cas-based modifications for therapeutic applications: a review | |
| Schindele et al. | Transforming plant biology and breeding with CRISPR/Cas9, Cas12 and Cas13 | |
| Tang et al. | Class 2 CRISPR/Cas: an expanding biotechnology toolbox for and beyond genome editing | |
| EP3347467B1 (en) | Full interrogation of nuclease dsbs and sequencing (find-seq) | |
| Richard et al. | Highly specific contractions of a single CAG/CTG trinucleotide repeat by TALEN in yeast | |
| Simeonov et al. | CRISPR-based tools in immunity | |
| RU2016101246A (ru) | Направленная интеграция | |
| RU2019135885A (ru) | Мультиплексная геномная инженерия, направляемая рнк | |
| JP2016027807A5 (OSRAM) | ||
| WO2015200334A4 (en) | Nuclease-mediated dna assembly | |
| HRP20190949T1 (hr) | Metode i kompozicije za ciljanu genetičku modifikaciju upotrebljenim vodičem rnas | |
| CN104805078A (zh) | 用于高效基因组编辑的rna分子的设计、合成及其应用 | |
| JP2016502840A5 (OSRAM) | ||
| Broothaerts et al. | New genomic techniques: State-of-the-art review | |
| Richard | Shortening trinucleotide repeats using highly specific endonucleases: a possible approach to gene therapy? | |
| Cao et al. | The multiplexed CRISPR targeting platforms | |
| Mota et al. | CRISPR/Cas Class 2 systems and their applications in biotechnological processes | |
| Malina et al. | Adapting CRISPR/Cas9 for functional genomics screens | |
| Mosbach et al. | Resection and repair of a Cas9 double-strand break at CTG trinucleotide repeats induces local and extensive chromosomal deletions | |
| Park et al. | Genome editing of structural variations: modeling and gene correction | |
| Ran | CRISPR-Cas: Development and applications for mammalian genome editing | |
| Sakuma et al. | CRISPR/Cas9: the leading edge of genome editing technology | |
| Samashaptak et al. | CRISPR-cas Methods: Culminating in Crescendo of the COVID-19 Pandemic to FELUDA Test |